Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-controlled Confirmatory Study of Galantamine (R113675) for Alzheimer's Type Dementia

NCT00814801 is registered in ClinicalTrials.gov with Janssen Pharmaceutical K.K. as lead sponsor.

NCT NCT00814801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00814801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-controlled Confirmatory Study of Galantamine (R113675) for Alzheimer's Type Dementia
Lead sponsor
Janssen Pharmaceutical K.K.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
September 30, 2008
Enrollment
580 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease